 NEWTOWN, Pa., Sept. 01, 2022 GLOBE NEWSWIRE -- Onconova Therapeutics, Inc. NASDAQ: ONTX, Onconova, a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that the Company will be participating virtually in the H.C. Wainwright 24th Annual Global Investment Conference, which is taking place in a hybrid format at the Lotte New York Palace Hotel. 